• Explore /
  • Poster
  • / INO-5401 and INO-9012 delivered intramuscularly (IM) with electroporation (EP) in combination with cemiplimab (REGN2810) in newly diagnosed glioblastoma (GBM): Interim results.

INO-5401 and INO-9012 delivered intramuscularly (IM) with electroporation (EP) in combination with cemiplimab (REGN2810) in newly diagnosed glioblastoma (GBM): Interim results.

Abstract Video & Slides Poster

Authors

null

David A. Reardon

Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA

David A. Reardon , Steven Brem , Arati Suvas Desai , Stephen Joseph Bagley , Sylvia Christine Kurz , Macarena Ines De La Fuente , Seema Nagpal , Mary Roberta Welch , Adilia Hormigo , Nicholas Carroll , Sarah K Bartra , Patricia Campbell , Kamalnayan Bhatt , Israel Lowy , Jean Boyer , Kimberly Kraynyak , Matthew P Morrow , Trevor McMullan , David B. Weiner , Jeffrey Skolnik

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Discussion Session

Session Title

Central Nervous System Tumors

Track

Central Nervous System Tumors

Sub Track

Central Nervous System Tumors

Clinical Trial Registration Number

NCT03491683

Citation

J Clin Oncol 38: 2020 (suppl; abstr 2514)

DOI

10.1200/JCO.2020.38.15_suppl.2514

Abstract #

2514

Poster Bd #

5

Abstract Disclosures

Similar Posters

First Author: David A. Reardon

First Author: David A. Reardon

First Author: Shiao-Pei S. Weathers

First Author: David A. Reardon